Baxter Hemodialysis Therapy Linked to 25% Lower Mortality Rate for up to Four Years

 

• Four-year study involved more than 1,000 dialysis patients from a large dialysis provider in Colombia
• Study compared Baxter’s HDx therapy enabled by Theranova dialyzer with high-flux hemodialysis

https://www.businesswire.com/news/home/20240529271887/en